Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Higher CRBP1 levels are linked to more severe alopecia areata.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

New research is helping develop better treatments for alopecia areata.

Jarilla-Coffea extract gel effectively and safely increases eyelash and eyebrow thickness in women.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

A woman with severe hair loss was successfully treated with the drug adalimumab.

A girl with lupus had unusually long and thick eyelashes, a rare symptom of her condition.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Low vitamin D levels are linked to hair loss, and vitamin D might help treat it.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

New understanding of hair loss could lead to better treatments.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.